Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Du, Boyu  [Clear All Filters]
2024
Wu Q, Liu Y, Liang J, Dai A, Du B, Xi X, Jin L, Guo Y. Baricitinib relieves DSS-induced ulcerative colitis in mice by suppressing the NF-κB and JAK2/STAT3 signalling pathways. Inflammopharmacology. 2024.
Zhu M, Yu R, Liu Y, Geng X, Liu Q, Liu S, Zhu Y, Li G, Guo Y, Xi X, et al. LncRNA H19 Participates in Leukemia Inhibitory Factor Mediated Stemness Promotion in Colorectal Cancer Cells. Biochem Genet. 2024.
2023
Gao Y, Li Y, Zhu Y, Luo Q, Lu Y, Wen K, Du B, Xi X, Li G. Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer. Curr Cancer Drug Targets. 2023.
Du B, Yu R, Geng X, Li Y, Liu Y, Liu S, Li F, Yu QQ, Guo Y, Xi X. The function of MSP-activated γδT cells in hepatocellular carcinoma. Int Immunopharmacol. 2023;124(Pt A):110893.
Deng T, Lei F, Wang Z, Wang Y, Li G, Zhu Y, Du B, Xi X. MCP-1/CCR2 axis is involved in the regulation of γδT cells in lupus nephritis. Scand J Immunol. 2023;98(4):e13305.
2022
Xi X, Deng T, Qiu F, Zhu Y, Li Y, Li G, Guo Y, Du B. Leukemia Inhibitory Factor Impairs the Function of Peripheral γδT Cells in Patients with Colorectal Cancer. Immunol Invest. 2022:1-14.
2020
Du B, Fan X, Lei F, Zhang S, Li G, Xi X. Comparative transcriptome analysis reveals a potential role for CaMK4 in γδT17 cells from systemic lupus erythematosus patients with lupus nephritis. Int Immunopharmacol. 2020;80:106139.